Download PDF
J Neurol Surg B Skull Base 2022; 83(S 02): e555-e563
DOI: 10.1055/s-0041-1735558
Original Article

Treatment and Prognosis of Inflammatory Pseudotumor of the Skull Base

Sidney J. Perkins 
1   Medical School, University of Michigan Medical School, Ann Arbor, Michigan, United States
,
Rebecca Gao
2   Department of Otolaryngology—Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, United States
,
Tiffany A. Glazer
3   Department of Surgery, Division of Otolaryngology-Head and Neck Surgery, University of Wisconsin, Madison, Wisconsin, United States
,
Cher X. Zhao
4   Department of Otolaryngology, Harvard Medical School, Pediatric Otolaryngology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
,
Gregory Basura 
2   Department of Otolaryngology—Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, United States
,
Erin L. McKean
2   Department of Otolaryngology—Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, United States
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Background Inflammatory pseudotumor (IPT) of the skull base is a rare, locally destructive lesion managed with a variety of treatments. We explore the impact of treatment on outcome and assess the prognosis of IPT.

Methods This is a retrospective review of IPT of the skull base at a tertiary academic medical center. The primary outcome was radiographic progression after treatment. Outcome versus tumor location was also examined and a prognostic model was developed using a logistic regression.

Results The demographics of 21 patients with IPT are reported. Treatment consisted of corticosteroids (in 80.1% of patients), disease modifying antirheumatic drugs (DMARDs; 33.3%), surgical resection (28.6%), radiation (23.8%), antibiotics (14.3%), chemotherapy (rituximab; 9.5%), and antivirals (4.8%). At 50.7 months, 50.8% had radiographic progression. Local therapy trended toward having a better response than systemic therapy (p = 0.60). IPT of the orbit required 2.4 treatment modalities, compared with 2.0 for pharyngeal IPT, and 1.3 for posterior skull base masses (p = 0.14). A total of 75% orbital IPT underwent radiographic progression, compared with 71% of pharyngeal IPT and 50% of posterior skull base masses (p = 0.62). Sixteen patients were used to create the logistic model of radiographic progression. The Cox–Snell R 2 was 0.71 (p = 0.03). No individual variables were statistically significant.

Conclusion To our knowledge, this is among the largest sample of cases describing the presentation, treatment, and prognosis of IPT of the skull base. Our data suggest that there may be an improved response with local therapy over systemic therapy and better prognosis among posterolateral skull base masses.

Keywords

Inflammatory pseudotumor - skull base - plasma cell granuloma - inflammatory myofibroblastoma - fibroinflammatory pseudotumor


Publication History

Received: 12 April 2021

Accepted: 25 July 2021

Article published online:
10 September 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Brunn H. Two interesting benign lung tumors of contradictory histopathology. J Thorac Surg 1939; 9: 119-131
    CrossrefPubMedGoogle Scholar
  • 2 Narla LD, Newman B, Spottswood SS, Narla S, Kolli R. Inflammatory pseudotumor. Radiographics 2003; 23 (03) 719-729
    CrossrefPubMedGoogle Scholar
  • 3 Umiker WO, Iverson L. Postinflammatory tumors of the lung; report of four cases simulating xanthoma, fibroma, or plasma cell tumor. J Thorac Surg 1954; 28 (01) 55-63
    PubMedGoogle Scholar
  • 4 Magro G. Differential diagnosis of benign spindle cell lesions. Surg Pathol Clin 2018; 11 (01) 91-121
    CrossrefPubMedGoogle Scholar
  • 5 Lai LM, McCarville MB, Kirby P. et al. Shedding light on inflammatory pseudotumor in children: spotlight on inflammatory myofibroblastic tumor. Pediatr Radiol 2015; 45 (12) 1738-1752
    CrossrefPubMedGoogle Scholar
  • 6 Patnana M, Sevrukov AB, Elsayes KM, Viswanathan C, Lubner M, Menias CO. Inflammatory pseudotumor: the great mimicker. AJR Am J Roentgenol 2012; 198 (03) W217-27
    CrossrefPubMedGoogle Scholar
  • 7 Das Narla L, Siddiqi NH, Hingsbergen EA. Inflammatory pseudotumor of the right atrium. Pediatr Radiol 2001; 31 (05) 351-353
    CrossrefPubMedGoogle Scholar
  • 8 Kovach SJ, Fischer AC, Katzman PJ. et al. Inflammatory myofibroblastic tumors. J Surg Oncol 2006; 94 (05) 385-391
    CrossrefPubMedGoogle Scholar
  • 9 Zhang Z, Fu W, Wang M. et al. IgG4-related inflammatory pseudotumor of the brain parenchyma: a case report and literature review. Acta Neurol Belg 2018; 118 (04) 617-627
    CrossrefPubMedGoogle Scholar
  • 10 Inada T, Yano T, Shima S. et al. Inflammatory pseudotumor of the spleen. Intern Med 1992; 31 (07) 941-945
    CrossrefPubMedGoogle Scholar
  • 11 Teoh JY, Chan NH, Cheung HY, Hou SS, Ng CF. Inflammatory myofibroblastic tumors of the urinary bladder: a systematic review. Urology 2014; 84 (03) 503-508
    CrossrefPubMedGoogle Scholar
  • 12 Sadeeq KJ, Yaqo RT, Mohammed AA. Inflammatory pseudotumor of the tunica albuginea and the tunica vaginalis: case-report. Urol Case Rep 2019; 26: 100954
    CrossrefPubMedGoogle Scholar
  • 13 Hamzaoui L, Medhioub M, Mahmoudi M, Chelbi E, Bouzaidi K, Msadak Azouz M. Inflammatory pseudotumor of the liver. Presse Med 2016; 45 (09) 804-807
    CrossrefPubMedGoogle Scholar
  • 14 Park SB, Lee JH, Weon YC. Imaging findings of head and neck inflammatory pseudotumor. AJR Am J Roentgenol 2009; 193 (04) 1180-1186
    CrossrefPubMedGoogle Scholar
  • 15 Kansara S, Bell D, Johnson J, Zafereo M. Head and neck inflammatory pseudotumor: case series and review of the literature. Neuroradiol J 2016; 29 (06) 440-446
    CrossrefPubMedGoogle Scholar
  • 16 Ginat DT, Bokhari A, Bhatt S, Dogra V. Inflammatory pseudotumors of the head and neck in pathology-proven cases. J Neuroradiol 2012; 39 (02) 110-115
    CrossrefPubMedGoogle Scholar
  • 17 Desai SV, Spinazzi EF, Fang CH. et al. Sinonasal and ventral skull base inflammatory pseudotumor: a systematic review. Laryngoscope 2015; 125 (04) 813-821
    CrossrefPubMedGoogle Scholar
  • 18 Marinelli JP, Marvisi C, Vaglio A. et al. Manifestations of skull base IgG4-related disease: a multi-institutional study. Laryngoscope 2020; 130 (11) 2574-2580
    CrossrefPubMedGoogle Scholar
  • 19 Korlepara R, Guttikonda VR, Madala J, Taneeru S. Inflammatory myofibroblastic tumor of mandible: a rare case report and review of literature. J Oral Maxillofac Pathol 2017; 21 (01) 136-139
    CrossrefPubMedGoogle Scholar
  • 20 Spinazzi EF, Desai SV, Fang CH. et al. Lateral skull base Inflammatory pseudotumor: a systematic review. Laryngoscope 2015; 125 (11) 2593-2600
    CrossrefPubMedGoogle Scholar
  • 21 Garg V, Temin N, Hildenbrand P, Silverman M, Catalano PJ. Inflammatory pseudotumor of the skull base. Otolaryngol Head Neck Surg 2010; 142 (01) 129-131
    CrossrefPubMedGoogle Scholar
  • 22 Alyono JC, Shi Y, Berry GJ. et al. Inflammatory pseudotumors of the skull base: meta-analysis. Otol Neurotol 2015; 36 (08) 1432-1438
    CrossrefPubMedGoogle Scholar
  • 23 Lee DK, Cho YS, Hong SH, Chung WH, Ahn YC. Inflammatory pseudotumor involving the skull base: response to steroid and radiation therapy. Otolaryngol Head Neck Surg 2006; 135 (01) 144-148
    CrossrefPubMedGoogle Scholar
  • 24 Ortlip TE, Drake VE, Raghavan P. et al. Inflammatory pseudotumor of the temporal bone: a case series. Otol Neurotol 2017; 38 (07) 1024-1031
    CrossrefPubMedGoogle Scholar
  • 25 Butrynski JE, D'Adamo DR, Hornick JL. et al. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med 2010; 363 (18) 1727-1733
    CrossrefPubMedGoogle Scholar
  • 26 Garcia BA, Tinsley S, Schellenberger T, Bobustuc GC. Recurrent inflammatory pseudotumor of the jaw with perineural intracranial invasion demonstrating sustained response to Rituximab. Med Oncol 2012; 29 (04) 2452-2455
    CrossrefPubMedGoogle Scholar